Please note the NCRI no longer supports the NCRI groups. The following information is for information purposes only.

The NCRI Groups bring the cancer research community together to develop practice-changing research, from basic to clinical research and across all cancer types. We work to improve the scientific understanding of cancer, develop cancer treatments and to lessen symptoms and improve the quality of life for cancer patients. Our groups are thought leaders that set and drive the UK research agenda, particularly in strategic, cross-cutting areas of unmet need.

We identify the most pressing issues to form the groups priority areas. Working on a three-year cycle, we ensure that our priorities are relevant to patients and consider any developments in cancer research. We follow a bottom-up approach to develop our priority areas by engaging with the broad membership of our network and NCRI Partners, government bodies, funders and international organisations. Through this process, we identify the key challenges the community is facing and the key questions the community needs to address to benefit patients.

Each group tackles their priority areas by forming time-limited working groups that allow them to adapt to the changing research landscape, addressing their priority areas in a targeted manner. When one working group finishes, capacity is transferred to a new working group ready to tackle the next priority area.

The NCRI Groups consist of the following groups:

Bladder & Renal Group, Bone Metastases Group, Brain Group, Breast Group, Children’s Group, Colorectal Group, Gynaecological Group, Haematological Oncology Group, Head & Neck Group, Living With & Beyond Cancer Group, Lung Group, Lymphoma Group, Pathology group, Prostate Group, Radiotherapy Group, Sarcoma Group, Screening, Prevention & Early Diagnosis Group, Skin Group, Teenage and Young Adult & Germ Cell Tumours Group and Upper Gastrointestinal Group.